Yuhan Corporation (KRX:000105)

South Korea · Delayed Price · Currency is KRW · Preferred Stock

85,300

+1,900 (2.28%)

Apr 8, 2026, 3:30 PM KST

-6.88% (1Y)

Market Cap	7.45T -18.7%
Revenue (ttm)	2.19T +5.7%
Net Income	194.08B +174.6%
EPS	2,599.51 +175.6%
Shares Out	n/a
PE Ratio	38.40
Forward PE	42.92
Dividend	610.00 (0.72%)
Ex-Dividend Date	Feb 26, 2026

Volume	1,397
Average Volume	1,660
Open	83,500
Previous Close	83,400
Day's Range	83,500 - 85,500
52-Week Range	77,500 - 117,200
Beta	n/a
RSI	44.41
Earnings Date	May 15, 2026

About Yuhan

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperl... [Read more]

Industry Medicinal Chemicals and Botanical Products

Sector Healthcare

Founded 1926

Employees 2,067

Stock Exchange Korea Stock Exchange

Ticker Symbol 000105